Search

As the U.S. seeks to jumpstart a hydrogen economy with the creation of Regional Clean Hydrogen Hubs (H2Hubs), Saul Ewing stands ready to advise clients in the energy, transportation, industrial, manufacturing and agribusiness industries on next steps. The H2Hubs will accelerate the commercial-scale...

During more than 30 years of practice, Richard Ivans has served as lead counsel in numerous complex business, corporate, real estate and real estate finance transactions. These transactions have involved mergers and acquisitions, asset sales, formations of business entities and joint ventures...

Dan Skowronski joined Saul Ewing in 2008 after having provided legal services to a national energy company and its affiliates in various in-house capacities between 1986 and 2008, as well as holding various executive leadership positions with that family of companies. Dan has broad experience in...

Domingos Silva is co-chair of the firm's Intellectual Property Practice with extensive experience in the pharmaceutical, chemical, biotechnology, diagnostics, biochemistry, and materials science areas. Domingos has a Ph.D. in Organic Chemistry from Princeton University and conducted his post...

David Sartorio focuses his practice on corporate transactions including mergers and acquisitions, control and non-control investments, joint ventures and strategic partnerships. David has experience advising companies ranging from private start-up and growth companies to large public companies...

The Inflation Reduction Act is driving unprecedented investment in renewable energy development in the United States, while the Energy Information Administration forecasts that natural gas development in the United States will continue to grow through 2050. Concerns about climate change are driving...

Vanessa Schoenthaler's practice focuses on corporate, securities and regulatory matters, with a particular emphasis on securities transactions, disclosure obligations, corporate governance, investment management and regulatory compliance. Vanessa's corporate finance experience ranges from advising...

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...